Clinical Trials

54 enrolled

Biliary Tract Neoplasms, Duodenal Neoplasms, Pancreatic Neoplasms, Pancreatitis, Chronic

NCT00640978 2025-05-01

Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic Cancer

16 enrolled 4 charts

Neoplasm Metastasis, Pancreatic Neoplasms

NCT05515705 2025-05-01

APEUS-Nav1

21 enrolled

Pancreatic Diseases, Pancreatic Neoplasms

NCT03820544 2025-04-30

SEMS Placement Before Surgery in Unblocking Bile Duct in Patients With Periampullary Pancreatic Cancer With Severe Obstructive Jaundice

4 enrolled 6 charts

Pancreatic Neoplasms

NCT04809766 2025-04-20

Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

9 enrolled

Pancreatic Neoplasms

NCT04476537 2025-04-03

HIPPOCRATES

16 enrolled 1 chart

Pancreatic Neoplasms

NCT05494866 2025-03-25

IntenSify

6 enrolled

Adenocarcinoma, Carcinoma, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Pancreatic Neoplasms

NCT03520790 2025-03-21

Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer

36 enrolled

Pancreatic Neoplasms

NCT00881621 2025-03-03

Lapatinib and Capecitabine for Second Line Treatment of Pancreas Cancer

17 enrolled 10 charts

Pancreatic Neoplasms

NCT05523154 2025-02-18

"Answers in Hours" A Randomized Controlled Trial Using Microbiome Metagenomics for Bile Duct Cultures

8 enrolled 13 charts

Pancreatic Neoplasms

NCT03822936 2025-02-13

PIOPPO

30 enrolled

Pancreatic Neoplasms

NCT04916236 2025-01-24

SHERPA

24 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Colorectal Neoplasms

NCT02671890 2025-01-07

Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic Cancer

16 enrolled

Pancreatic Neoplasms

NCT05546411 2024-12-17

A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer

8 enrolled 11 charts

Pancreatic Neoplasms

NCT04136769 2024-12-09

PREVADER

3 enrolled

Pancreatic Neoplasms

NCT04536077 2024-10-08

Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients

16 enrolled 9 charts

Pancreatic Neoplasms

NCT04517448 2024-09-26

EQLVCPAL

31 enrolled

Biliary Tract Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT03716596 2024-09-20

CISPD-2

8 enrolled

Pancreatic Neoplasms

NCT02798003 2024-08-06

Food Reward in Cachexia Induced by Acute or Chronic Disease

44 enrolled

GastrointestinalThoracic

Cachexia, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Pulmonary Disease, Chronic Obstructive

NCT03956056 2024-07-17

Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy

12 enrolled 11 charts

Phase EARLY_PHASE1 Terminated

Pancreatic Neoplasms

NCT03492164 2024-06-12

In Vivo PARP-1 Expression With 18F-FTT PET/CT in Pancreatic Cancer

6 enrolled

Pancreatic Neoplasms

NCT04843306 2024-06-07

Breath-Hold Technique for Pancreatic Stereotactic Body Radiation Therapy (SBRT) Patients

4 enrolled

Pancreatic Neoplasms

NCT02902484 2024-06-03

Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer

Phase 1/2 Terminated

14 enrolled 9 charts

Pancreatic Neoplasms

NCT05116917 2024-05-28

INFLUENCE

19 enrolled

Influenza, Human, Pancreatic Neoplasms

NCT06164691 2024-05-21

Blue and Amber Light Exposure in Patients With Rectal and Pancreatic Cancer

2 enrolled 4 charts

Pancreatic Neoplasms, Rectal Neoplasms

NCT04390243 2024-05-06

Binimetinib and Encorafenib for the Treatment of Pancreatic Cancer in Patients With a Somatic BRAF V600E Mutation

6 enrolled 16 charts

Pancreatic Neoplasms

NCT03848182 2024-04-18

Analyzing Childhood Recall Antigens in Patients With Pancreatic Cancer

10 enrolled 7 charts

Pancreatic Neoplasms, Lipodystrophy, Congenital Generalized

NCT06371716 2024-04-17

Ex-vivo Ultrasound Guided Radiofrequency Ablation on Pancreatic Solid Lesions

45 enrolled

Pancreatic Neoplasms

NCT03724435 2024-03-18

ARRAY

21 enrolled

Phase EARLY_PHASE1 Terminated

Pancreatic Neoplasms

NCT03519308 2024-03-15

A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer

3 enrolled 13 charts

Pancreatic Neoplasms

NCT03878524 2024-03-04

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

BreastClassical hematologyGastrointestinalGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cell

2 enrolled

Anemia, Blast Crisis, Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Thrombocytosis, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT00322712 2024-02-05

INST 0603C Patients With Unresectable/Metastatic Pancreatic Cancer Treated in the UNM Cancer

12 enrolled 4 charts

Pancreatic Neoplasms

NCT03376659 2024-02-05

Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma

Phase 1/2 Terminated

8 enrolled 14 charts